Dr. Lea Lowenfeld, MD

Dr. Lowenfeld practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Lowenfeld's NPI, 1134410004, was assigned on April 27, 2011. Dr. Lowenfeld graduated from Perelman School of Medicine - Philadelphia in 2011. Dr. Lowenfeld holds New York license 300027.

Dr. Lowenfeld's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Lowenfeld's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Lowenfeld to 2 more clinical labs, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lowenfeld practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Lowenfeld's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Lowenfeld is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dmand AI has Dr. Lowenfeld's licenses on file in 5 states: New York, Florida, New Jersey, California and Pennsylvania.

Dmand AI lists colonoscopy, colon removal, gastrointestinal obstruction and hemorrhoids among the conditions Dr. Lowenfeld treats.

CMS data shows 390 Medicare services from Dr. Lowenfeld across 11 procedure codes in 2024, for 180 Medicare patients. Medicare paid $38,738 for them.

CMS counts 180 Medicare patients who saw Dr. Lowenfeld in 2024. The largest group is 65 to 74, with 71 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lowenfeld's median patient age at 55, with 57% women.

In 2024, Dr. Lowenfeld wrote 15 Medicare Part D claims. 100% of them were for generic drugs. They cover 2 drugs, with $186 in total drug cost. In 2017, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Lowenfeld for performance year 2024, reported through an alternative payment model (APM). Dr. Lowenfeld accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lowenfeld as offering telehealth. CMS counts 29 procedures of colonoscopy by Dr. Lowenfeld, more than 53% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 14 papers to Dr. Lowenfeld, published from 2014 to 2023. 2016 was the busiest year, with 4. The most frequent topics are Neoadjuvant Therapy, Breast Neoplasms and Cancer Vaccines. Dr. Lowenfeld has published most often in Ann Surg Oncol. Dr. Lowenfeld's most frequent co-authors are Jashodeep Datta, MD, Brian J. Czerniecki, MD and Carla S. Fisher, MD.

CMS Open Payments shows 59 general payments to Dr. Lowenfeld from 11 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 78% of the total. Olympus America Inc. paid the most, $14,021.

Dr. Lowenfeld graduated from Perelman School of Medicine - Philadelphia in 2011.

Dr. Lowenfeld is in network with 15 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.